Safe Use of Interleukin-17 Inhibitors for Psoriasis and Psoriatic Arthritis in Two Patients With a History of Lymphoproliferative Disease. J of Skin 2020, 4 (3), 256-259. https://doi.org/10.25251/skin.4.3.7.